- Home
- FRAF vs TLSA Comparison
FRAF vs TLSA Comparison
Compare FRAF & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRAF | TLSA |
|---|---|---|
| Founded | 1906 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.2M | 192.1M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | FRAF | TLSA |
|---|---|---|
| Price | $49.78 | $1.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 59.0K | ★ 316.9K |
| Earning Date | 01-27-2026 | 05-06-2025 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | ★ 88.84 | N/A |
| EPS | ★ 4.74 | N/A |
| Revenue | ★ $85,923,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.47 | ★ N/A |
| Revenue Growth | ★ 24.15 | N/A |
| 52 Week Low | $32.39 | $0.69 |
| 52 Week High | $59.95 | $2.60 |
Technical Indicators
Market Signals| Indicator | FRAF | TLSA |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 42.35 |
| Support Level | $48.32 | $1.33 |
| Resistance Level | $50.25 | $1.77 |
| Average True Range (ATR) | 1.93 | 0.11 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 48.71 | 20.41 |
Price Performance
Historical ComparisonAbout FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.